Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.

Autor:	Allan, J. M.1 James.Allan@newcastle.ac.uk, Sunter, N. J.1, Bailey, J. R.2, Pettitt, A. R.3, Harris, R. J.3, Pepper, C.4, Fegan, C.5, Hall, A. G.1, Deignan, L.1, Bacon, C. M.1, Pointon, J. C.2, Houlston, R. S.6, Broderick, P.6, Mainou-Fowler, T.7, Jackson, G. H.8, Summerfield, G.9, Evans, P. A.10, Strefford, J. C.11, Parker, A.12, Oscier, D.12
Zdroj:	Leukemia (08876924). Apr2010, Vol. 24 Issue 4, p877-881. 5p. 3 Charts, 1 Graph.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu